Axe Compute Sells Helomics to DataMeds for 19.99% Stake Plus $1.36M Convertible Note
AGPU has more than doubled off its 52-week low of $1.03.
Summary
Axe Compute sold its Helomics cancer diagnostics subsidiary to DataMeds AI for a 19.99% equity stake plus a $1.36M convertible note, completing its transition to a pure-play GPU-as-a-Service company.
Key Events · M&A and Partnerships · AGPU
-
Helomics Sold to DataMeds AI
Axe Compute sold its wholly-owned Helomics subsidiary to DataMeds AI (NASDAQ: MEDS) on September 11, 2026, completing its exit from the legacy cancer diagnostics business.
-
Consideration: 19.99% Stake Plus Note
Axe Compute received 636,328 shares of DataMeds common stock (19.99% of shares outstanding) plus a $1,363,672 convertible note with a $1.00 per share conversion price.
-
12-Month Lock-Up on Consideration
The DataMeds shares and any shares from note conversion are subject to a 12-month lock-up, restricting Axe Compute's ability to monetize the stake until September 2027.
-
Pure-Play Neocloud Transition Complete
Helomics was the final operating business from Axe Compute's former identity as Predictive Oncology Inc.; the sale completes its strategic shift to a pure-play GPU-as-a-Service platform.
Analysis · AGPU · Crypto Assets
Axe Compute completed the sale of its final legacy business, Helomics, to DataMeds AI on September 11, 2026. The deal gives Axe Compute 636,328 shares of DataMeds — a 19.99% stake — plus a $1,363,672 convertible note at $1.00 per share. This is the final step in Axe Compute's transformation into a pure-play neocloud GPU-as-a-Service company, removing the last non-core operating business. The consideration is locked up for 12 months, so Axe Compute cannot immediately monetize the stake, but it retains upside exposure to DataMeds' oncology platform while freeing management and capital to focus entirely on its $1.3B+ AI infrastructure contract pipeline.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1605 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AGPU was trading at $12.92 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $149.8M. The 52-week trading range was $1.03 to $32.10. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.